Investments and Business

Databricks, one of the world's most valuable private technology companies, is raising billions of dollars in new funding as it chooses to delay its long-awaited public offering, sources familiar with the matter told CNBC. The San Francisco-based company is reportedly securing at least $5 billion in its latest funding round, with the potential to raise as much as $8 billion as discussions progress. This new round would push Databricks' valuation to $55 billion, making it one of the most valuable private technology companies globally. The funding round, according to insiders, is partly designed to allow employees to sell shares, easing…

US-China economic relations are facing new uncertainties after President-elect Donald Trump announced plans to impose an additional 10% tariff on all Chinese imports. The announcement, made on its social media platform Truth Social, signals a significant escalation in trade tensions between the world's two largest economies. Trump's statement came shortly after he revealed his intention to enact a 25% tariff on all imports from Mexico and Canada as one of his first executive actions on Jan. 20, the day he took office. This move is expected to effectively dismantle the existing regional free trade agreement between the three nations. Trump…

President-elect Donald Trump announced Friday his plan to nominate Scott Bessent, founder and CEO of Key Square Group LP, as Treasury secretary. The move places a seasoned hedge fund executive and Trump ally in a key role within the new administration's economic strategy. Bessent's appointment highlights Trump's focus on appointing market-savvy figures to guide the country's economic policy. Bessent, 62, has emerged as a strong contender for the position alongside names such as former Federal Reserve governor Kevin Warsh and private equity executive Marc Rowan. Known as a Wall Street heavyweight, Bessent brings decades of financial experience to the table…

President-elect Donald Trump announced Robert F. Kennedy Jr., a longtime vaccine skeptic and former independent presidential candidate, as his nominee to head the Department of Health and Human Services (HHS). The decision, revealed Thursday, sparked widespread apprehension in the public health community and left the pharmaceutical and biotech industries braced for potential upheaval. Kennedy, a polarizing figure because of his controversial views on vaccines and public health policies, will need Senate confirmation to assume the role. However, Trump has hinted at the possibility of bypassing the confirmation process by making a suspension appointment if necessary. If confirmed, Kennedy would oversee…